title: Treatment Maintenance Duration of Dual Therapy with Metformin and Sitagliptin in Type 2 Diabetes - Real-World Data From Odyssee Study.
authors.affiliation: Merck (MSD France), Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Leproust
authors.affiliation: INSERM U744, Lille, France.
authors.forename: J
authors.initials: J
authors.lastname: Dallongeville
authors.affiliation: Service d'Endocrinologie-Diabétologie-Nutrition, Bondy, France.
authors.forename: P
authors.initials: P
authors.lastname: Valensi
authors.affiliation: Cegedim Strategic Data, Boulogne-Billancourt, France.
authors.forename: E
authors.initials: E
authors.lastname: Boutmy
authors.affiliation: Merck (MSD France), Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Moisan
authors.affiliation: Laboratoires MSD France, Courbevoie, France.
authors.forename: C
authors.initials: C
authors.lastname: Chanut-Vogel
authors.affiliation: ESSEC, Cergy-Pontoise, France.
authors.forename: G
authors.initials: G
authors.lastname: de Pouvourville